Articles with public access mandates - Mark FrydenbergLearn more
Not available anywhere: 13
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
A Kneebone, C Fraser-Browne, GM Duchesne, R Fisher, M Frydenberg, ...
The Lancet Oncology 21 (10), 1331-1340, 2020
Mandates: National Health and Medical Research Council, Australia
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 …
GM Duchesne, HH Woo, JK Bassett, SJ Bowe, C D'Este, M Frydenberg, ...
The Lancet Oncology 17 (6), 727-737, 2016
Mandates: National Health and Medical Research Council, Australia
Systematic review links the prevalence of intraductal carcinoma of the prostate to prostate cancer risk categories
LH Porter, MG Lawrence, D Ilic, D Clouston, DM Bolton, M Frydenberg, ...
European urology 72 (4), 492-495, 2017
Mandates: National Health and Medical Research Council, Australia
A pro‐tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment
SJ Ellem, RA Taylor, L Furic, O Larsson, M Frydenberg, D Pook, ...
The Journal of pathology 234 (1), 86-98, 2014
Mandates: National Health and Medical Research Council, Australia
Hedgehog signaling is active in human prostate cancer stroma and regulates proliferation and differentiation of adjacent epithelium
SE Wilkinson, L Furic, G Buchanan, O Larsson, J Pedersen, ...
The Prostate 73 (16), 1810-1823, 2013
Mandates: National Health and Medical Research Council, Australia
Overall survival of men with metachronous metastatic hormone-sensitive prostate cancer treated with enzalutamide and androgen deprivation therapy
CJ Sweeney, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ...
European Urology 80 (3), 275-279, 2021
Mandates: National Health and Medical Research Council, Australia, Canadian Cancer Society
Enhancing active surveillance of prostate cancer: the potential of exercise medicine
DA Galvao, DR Taaffe, N Spry, RA Gardiner, R Taylor, GP Risbridger, ...
Nature Reviews Urology 13 (5), 258-265, 2016
Mandates: Australian Research Council
Neuroendocrine cells in prostate cancer correlate with poor outcomes: a systematic review and meta‐analysis
A Kannan, D Clouston, M Frydenberg, D Ilic, MN Karim, SM Evans, ...
BJU international 130 (4), 420-433, 2022
Mandates: US National Institutes of Health, National Health and Medical Research …
Beyond Prostate Imaging Reporting and Data System: combining magnetic resonance imaging Prostate Imaging Reporting and Data System and prostate-specific membrane antigen …
L Emmett, N Papa, TA Hope, W Fendler, J Calais, I Burger, M Eiber, ...
The Journal of Urology, 10.1097/JU. 0000000000004010, 2024
Mandates: Prostate Cancer UK
A decade of declining prostatectomy margin positivity within a prostate cancer clinical quality registry
N Papa, M Perera, JG Bensley, M Evans, J Millar, M Frydenberg, ...
Urologic Oncology: Seminars and Original Investigations 40 (12), 537. e19 …, 2022
Mandates: US National Institutes of Health
Treatment de‐intensification for low‐risk biochemical recurrence after radical prostatectomy: rational or risky?
MJ Roberts, G Hruby, A Kneebone, JM Martin, SG Williams, M Frydenberg, ...
BJU international 132 (2), 2023
Mandates: National Health and Medical Research Council, Australia, Medical Research …
Beyond PI-RADS: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen–Positron Emission Tomography/Computed …
L Emmett, N Papa, TA Hope, W Fendler, J Calais, I Burger, M Eiber, ...
Journal of Urology, 10.1097, 2024
Mandates: US National Institutes of Health, Prostate Cancer UK
MP72-11 A DECADE OF DECLINING PROSTATECTOMY MARGIN POSITIVITY WITHIN A PROSTATE CANCER CLINICAL QUALITY REGISTRY
M Perera, N Papa, J Bensley, M Evans, J Millar, M Frydenberg, D Murphy, ...
Journal of Urology 209 (Supplement 4), e1028, 2023
Mandates: US National Institutes of Health
Available somewhere: 79
Enzalutamide with standard first-line therapy in metastatic prostate cancer
ID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ...
New England Journal of Medicine 381 (2), 121-131, 2019
Mandates: National Health and Medical Research Council, Australia, Canadian Cancer Society
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...
European urology 73 (2), 178-211, 2018
Mandates: US National Institutes of Health, National Health and Medical Research …
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer
MJ Watt, AK Clark, LA Selth, VR Haynes, N Lister, R Rebello, LH Porter, ...
Science translational medicine 11 (478), eaau5758, 2019
Mandates: US National Institutes of Health, National Health and Medical Research …
Defining a standard set of patient-centered outcomes for men with localized prostate cancer
NE Martin, L Massey, C Stowell, C Bangma, A Briganti, A Bill-Axelson, ...
European urology 67 (3), 460-467, 2015
Mandates: UK Medical Research Council
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories
RA Taylor, M Fraser, J Livingstone, SMG Espiritu, H Thorne, V Huang, ...
Nature communications 8 (1), 13671, 2017
Mandates: National Health and Medical Research Council, Australia, Canadian Cancer …
EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU …
JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ...
European urology 77 (2), 223-250, 2020
Mandates: Cancer Research UK
Active surveillance for prostate cancer: a narrative review of clinical guidelines
SM Bruinsma, CH Bangma, PR Carroll, MS Leapman, A Rannikko, ...
Nature Reviews Urology 13 (3), 151-167, 2016
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program